medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2013, Number 4

<< Back Next >>

Rev ADM 2013; 70 (4)

Prevention of oral disease in patients with systemic disorders. Part II: Diabetes mellitus

Díaz GLM, Castellanos SJL

Language: Spanish
References: 56
Page: 169-176
PDF size: 154.17 Kb.


ABSTRACT

One of the consequences of the obesity epidemic that has affected both developed and developing countries in recent years has been the very significant increase in the prevalence of diabetes mellitus in Mexico, which represents a major health problem given its high impact on the quality of life of those affected, and the huge emotional, economic, social and cultural cost that it entails. This metabolic disease is the best example of two-way association that can occur between a systemic disease and oral one, in which both diseases are mutually influential. Poorly controlled diabetes will negatively impact on already established periodontitis. Furthermore, by generating a considerable amount of systemically distributed inflammatory chemical mediators, periodontal disease induces insulin resistance, so making it more difficult to ensure metabolic control in the patient. Similarly, periodontal treatment will give rise to improved glycemic control and the results of periodontal treatment will be more predictable in patients whose diabetes is under control. In this paper, the second of a series of two, we review the relationship between diabetes and periodontal disease, and the preventive protocols that must be implemented in order to make use, for the benefit of the patient, of the synergy that exists between these two processes.


REFERENCES

  1. Maitra A. Sistema endocrino. En: Kumar, V, Abbas AK, Fausto N, Aster JC. Robbins y Cotran. Patología estructural y funcional. 8ª ed. Barcelona, Elsevier 2010. pp. 1131-1146.

  2. World Health Organization. Department of Noncommunicable Disease Surveillance 2006.

  3. Encuesta Nacional de Salud y Nutrición 2012. Instituto Nacional de Salud Pública. Secretaría de Salud. México.

  4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Position statement. Diabetes Care. 2005; 2 (Suppl. 1): S37-S42.

  5. Mealey BL, Thomas WO. APP Commissioned Review. Diabetes mellitus and periodontal diseases, J Periodontol. 2006; 77: 1289-1303.

  6. Castellanos JL, Díaz-Guzmán L. Enfermedades en diabetes mellitus. Prevalencia y significancia clínica en 341 diabéticos de una población de 10,980 pacientes dentales. Revista de la Asociación Dental Mexicana. 1996; 53: 80-85.

  7. Castellanos JL, Díaz GL, Gay ZO. Alteraciones endocrinas. En: Castellanos JL, Díaz-Guzmán LM, Gay O. Medicina en odontología. Manejo dental de pacientes con enfermedades sistémicas. 2ª ed. México, El Manual Moderno, 2002. pp. 130-142.

  8. Castellanos JL, Díaz GL. Embarazo, enfermedades sistémicas de alto riesgo y enfermedad periodontal. Perinatol Reprod Hum. 2009; 23: 64-72.

  9. Inzucchi SE, Sherwin RS. Type 2 diabetes mellitus. In: Goldman L, Schafer AI. Goldman’s cecil internal medicine. 24ª ed. Philadelphia, Elsevier Saunders 2012. pp. e237: 1-14.

  10. Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R. Advanced glycation endproducts (AGEs) induce oxidant stress in gingival: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res. 1996; 31: 508-515.

  11. Karjalainen KM, Knuuttila MLE. The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin-dependent diabetes mellitus. J Clin Periodontol. 1996; 23: 1060-1067.

  12. Satrowijoto SH, van der Velden U, van Steenbergen TJM, Hillemans P, Hart AAM, de graaff J. Improved metabolic control, clinic periodontal status and subgingival microbiology in insulin-dependent diabetes mellitus. A prospective study. J Clin Periodontol. 1990; 17: 233-242.

  13. Gusberti FA, Syed SA, Bacon G, Grossman N, Loesche WJ. Puberty gingivitis in insulin-dependent diabetic children. I Cross-sectional observations. J Periodontol. 1983; 54 (12): 714-720.

  14. Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). JADA. 1982; 104: 653-660.

  15. Sbordone L, Ramaglia L, Barone A, Ciaglia RN, Iacomo VJ. Periodontal status and subgingival microbiota of insulin-dependent juvenile diabetics: A 3-year longitudinal study. J Periodontol. 1998; 69: 120-128.

  16. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol. 1991; 62: 123-130.

  17. Shlossman M, Knowler WC, Pettit DL, Genco RL. Type 2 diabetes mellitus and periodontal diseases. J Am Dent Assoc. 1990; 121: 532-536.

  18. Nishimura F, Takahashi K, Kurihara M, Takashiba S, Murayama Y. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol. 1998; 3: 20-29.

  19. Sastrowijoto SH, Hillemans P, van Steenbergen TJM, Abraham-Inpijn L, de GraaffJ. Periodontal condition and microbiology of healthy and disease periodontal pockets in type 1 diabetes mellitus patients. J Clin Periodontol. 1989; 16: 316-322.

  20. American Academy of Periodontology. Position paper. Diabetes and periodontal diseases. J Periodontol. 1999; 70: 935-49.

  21. Thorstensson H, Kuylenstierna J, Hugoson A. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol. 1996; 23: 194-202.

  22. Golub LM, Lee H-M, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998; 12: 12-26.

  23. Wstfeld E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after five years. J Clin Periodontol. 1996; 23: 92-100.

  24. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 1997; 24: 505-10.

  25. Rodrigues DC, Taba Jr. M, Novaes Jr. AB, Souza SLS, Grisi MFM. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol. 2003; 74: 1361-1367.

  26. Stewart JE, Wager KA, Friedlander AH, Zadeth HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol. 2001; 28: 306-10.

  27. Kiran M, Arpak N, Ünsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol. 2005; 32: 266-272.

  28. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol. 1998; 25: 112-124.

  29. Aldridge JP, Lester V, Watts TLP, Collins A, Viberti G, Wilson RF. Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. J Clin Periodontol. 1995; 22: 271-275.

  30. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, Genco RJ. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol. 1997; 68: 713-719.

  31. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol. 1996; 67: 1094-1102.

  32. Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodget J. The relationship between reduction in periodontal inflammation and diabetes control: A report of nine cases. J Periodontol. 1992; 63: 843-848.

  33. Geerts SO, Nys M, De Mol P, Charpenteir J, Albert A, Legrand V. Systemic realease of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002; 73: 73-78.

  34. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001; 72: 1221-1227.

  35. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol. 2005; 76: 2106-2115.

  36. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNFa secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol. 1997; 24: 8-16.

  37. Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol. 1997; 68: 127-135.

  38. Castellanos JL, Díaz GL. Frecuencia de peridontitis crónica asociada a padecimientos sistémicos en 2,000 pacientes. Rev ADM. 2002; 59: 122-127.

  39. US Department of Health and Human Services: Oral Health in America: A report of the Surgeon General. Rockville, MD, US Department of health and human services, National Institute of Dental and Craniofacial Research, National Institutes of Health, 2000.

  40. Seppälä B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol. 1994; 21: 161-165.

  41. Safkan-Seppälä B, Ainamo J. Periodontal conditions in insulin-dependent diabetes mellitus. J Clin Periodontol. 1992; 19: 24-29.

  42. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol. 2002; 30: 182-192.

  43. Barnett ML, Baker RL, Yancey JM, MacMillan DR, Kotoyan M. Absence of periodontitis in a population of insulin-dependent diabetes mellitus (IDDM) patient. J Periodontol. 1984; 55 (7): 402-405.

  44. Bridges RB, Anderson JW, Saxe SR, Gregory K, Bridges SR. Periodontal status of diabetic and non-diabetic men: effects of smoking, glycemic control, and socioeconomic factors. J Periodontol. 1996; 67: 1185-1192.

  45. Moore PA, Weyant RJ, Mongelluzzo MB, Myers DE, Rossie K, Guggenheimer J. Type 1 diabetes mellitus and oral health: assessment of periodontal disease. J Periodontol. 1999; 70: 409-417.

  46. Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996; 1: 1-36.

  47. Bacic M, Plancak D, Granic M. CPITN assessment of periodontal disease in diabetic patients. J Periodontol. 1988; 59 (12): 816-822.

  48. Guggenheimer J, Moore PA. Xerostomia, etiology, recognition and treatment. J Am Dent Assoc. 2003; 134 (1): 61-69.

  49. Tschoppe P, Wolgin M, Pischon N, Kielbassa AM. Etiologic factors of hyposalivation and consequences for oral health. Quintessence Int. 2010; 41: 321-333.

  50. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97: 28-46.

  51. Chavez EM, Taylor GW, Borrell LN, Ship JA. Salivary function and glycemic control in older persons with diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 89: 305-311.

  52. Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T. Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92: 281-291.

  53. Busato IMS, Aparecido S, Brancher JA, Grégio AMT, Naval MA, Azevedo-Alanis LR. Impact of xerostomía on the quality of life of adolescents with type 1 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 108: 376-382.

  54. Díaz-Arnold AM, Marek CA. The impact of saliva on patient care: a literature review. J Prosthet Dent. 2002; 88: 337-343.

  55. Beltrán-Aguilar ED, Goldstein JW, Lockwood SA. Fluoride varnishes: a review of their clinical use, cariostatic mechanism, efficacy and safety. JADA. 2000; 131: 589-596.

  56. Puig L, Castellanos JL. Odontología preventiva. En: Castellanos JL, Díaz-Guzmán LM, Gay O. Medicina en Odontología. Manejo dental de pacientes con enfermedades sistémicas. 2ª ed. México, El Manual Moderno 2002. pp. 305-317.




2020     |     www.medigraphic.com